Citadel Advisors »

Aslan Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Aslan Pharmaceuticals (ASLN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Aslan Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aslan Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aslan Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $73k 119k 0.62
2023-12-31 $255k 489k 0.52
2023-09-30 $330k 178k 1.85
2023-06-30 $635k 174k 3.65
2023-03-31 $1.6M 542k 2.90

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Aslan Pharmaceuticals

BVF
Velan Capital Investment Management
Shay Capital
Sio Capital Management
Schonfeld Strategic Advisors
Citadel Advisors
ADAR1 Capital Management
FNY Investment Advisers
Millennium Management
Ikarian Capital
Onyx Bridge Wealth Group
Waterfront Wealth
Walleye Trading Advisors
XTX Topco
Morgan Stanley

View all funds holding Aslan Pharmaceuticals